Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (nine amino acids) originally isolated from the central nervous system during studies of electrically induced sleep. DSIP is named for its association with delta sleep, or slow-wave sleep, but has since been studied for broader roles in regulating neuroendocrine activity, stress response, and metabolic processes. First described between 1963 and 1977, DSIP has been examined in animal and human research models for its potential effects on sleep cycles, hormonal balance, pain perception, stress tolerance, and even cellular longevity.
DSIP is hypothesized to modulate sleep and stress by interacting with multiple receptor systems and signaling pathways:- GABA and NMDA Receptors: DSIP may enhance inhibitory neurotransmission through GABA, while reducing excitatory activity at NMDA (glutamate-linked) receptors. This dual action may shorten sleep onset and promote deep (slow-wave) sleep.- Opioid Receptors: Research suggests DSIP influences opioid signaling, potentially contributing to its reported roles in sleep regulation, pain modulation, and alleviation of withdrawal symptoms.- Alpha 1-Adrenergic Receptor: Found in the pineal gland, this receptor may link DSIP to circadian rhythm regulation and stress tolerance.- Endocrine Effects: Studies suggest DSIP may influence luteinizing hormone (LH), growth hormone (GH), and other hormones typically secreted during sleep, connecting the peptide to neuroendocrine regulation.
| CAS #: 62568-57-4 Molecular Formula: C35H48N10O15 Molecular Weight: 848.824 g/mol |
Other Titles: DSIP Nonapeptide, Emideltide
– In feline models, DSIP increased total sleep and slow-wave sleep within one hour of administration, maintaining effects for up to seven hours.- Human studies have suggested increased sleep efficiency, shortened sleep onset, and greater overall restfulness.
– DSIP has been observed to elevate luteinizing hormone (LH) without affecting follicle-stimulating hormone (FSH).- Evidence suggests it may stimulate GH release via hypothalamic and pituitary pathways, potentially linking DSIP’s sleep-inducing role to natural GH surges during slow-wave sleep.
– Animal studies indicate DSIP influences markers such as substance P, beta-endorphin, and corticosterone, suggesting it may buffer stress responses and modulate the opioidergic system.- Notably, corticosterone levels dropped shortly after DSIP exposure, aligning with stress-protective actions.
– DSIP has been associated with extended lifespan in animal models, reduced chromosomal damage, and lower incidence of malignancies.- Proposed antioxidant mechanisms include reduced lipid peroxidation and increased activity of endogenous defense systems (superoxide dismutase, catalase, ceruloplasmin).
DSIP remains an experimental peptide of interest for its proposed influence on sleep architecture, stress adaptation, hormonal regulation, and cellular protection. While mechanisms are still under study, research points toward DSIP’s multifaceted role in neuroendocrine and metabolic systems.
The mission of BioGenix Peptides™ is to provide researchers with the highest-quality, Ultra-Pure Series™ compounds to help unlock the full potential of this evolving field. With precision, purity, and scientific integrity at the core of our operations, BioGenix Peptides™ is dedicated to supporting responsible exploration and discovery
Products from BioGenix Peptides™ are not intended for human consumption. They are supplied exclusively for in-vitro and pre-clinical research purposes.
By purchasing or using these products, the Customer accepts full responsibility for their handling and use, and agrees to indemnify and hold BioGenix Peptides™ harmless from any claims resulting from misuse
Having trouble viewing? Use the buttons below to download or open the certificate.
In Stock